Biomarkers in Hematology

Biomarkers in hematology were mostly of protein biomarkers which are helpful to detect the tumours early location and mainly to identify bosom growth, these biomarkers simply used to measure and indicate the severity level of disease state. Where as these haematological biomarkers are helpful in identifying the blood disease. Patients who are suspected with pancreatic malignancy will face CT sweep. Recolors neoplastic pancreatic cells will empower the certainty to identify pancreatic tumour by pathologist and hence suitable for treating disease condition. For pancreatic disease a novel drug discovery in biomarkers like 
BI-010 and IHC markers are developed.

  • Drug Targeting
  • Monitoring Treatment Response
  • Pharmacodynamics and Pharmacokinetics

Related Conference of Biomarkers in Hematology


November 25-26, 2019

17th World Hematology & Blood Disorders Conference


HOLIDAY INN PARIS - PORTE DE CLICHY 2 Rue du 8 Mai 1945, 92110 Clichy, France

March 16-17, 2020

18th World Hematology Congress

London, UK
November 23-24, 2020

Annual Hematology Congress

Dubai, UAE
July 20-21,2020

World Summit on Hematology and Cell Therapy

Tokyo, Japan

Biomarkers in Hematology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in